Category Biotech Stocks

Why Evelo (EVLO): is up 26.92%

Why Evelo (EVLO): is up 26.92%
Evelo (EVLO) announced on December 9th that the company is developing a new modality of orally delivered medicines which act in the small intestine with systemic effects, today announced that it is prioritizing EDP1908 as its lead clinical candidate in…

Why Arvinas (ARVN) surged over 80% today

Why Arvinas (ARVN) surged over 80% today
Shares of Arvinas (ARVN) surged more than 80% today on news of clinical interim results for their PROTAC® Protein Degraders ARV-471 and ARV-110. ARV-471 demonstrates evidence of anti-tumor activity, and potential for best-in-class safety, and estrogen receptor (ER) degradation profile…